Follicular repigmentation in vitiligo – narrowband UVB phototherapy

Wednesday, July 6th, 2011

Figures 1 & 2. A vitiligo patient before and after NB-UVB treatment. Images courtesy of Pearl E Grimes, MD.

Vitiligo is a common skin depigmentation disorder in which the melanocytes, the skin cells which produce melanin pigment, are progressively lost. Clinically, when vitiliginous lesions (the ‘patches’ of skin which have lost their pigment) are repeatedly exposed to an intensive dose of narrowband UVB radiation (308 or 311-313nm), it is common to see small spots, sometimes described as ‘freckles’ or  ‘islands’, of repigmentation forming within the lesion. This occurs because the melanocytes producing this melanin have developed from stem cells reserved in the bulge region of the hair follicle, known as the niche. Their development is stimulated by NB-UVB and they migrate to the skin directly surrounding the hair follicle from which they were derived. As the melanocytes continue to travel through the skin and produce melanin, these ‘islands’ begin to spread and merge, eventually creating broader, but seldom perfect, repigmentation in the treated area (see Figures 1 & 2). (more…)

Bookmark and Share

Changing the rules in pharmaceutical development: wider significance of Clinuvel’s progressive communication channels

Monday, May 17th, 2010

Communication remains key, whereby content of news and material facts dominate over frequency of news flow. Here our adagium no news signifies focus and good news. A total devotion to this one project, and execution on clinical and regulatory development while finding a balance in available funds, are the core activities en route to commercialisation of afamelanotide.

The significance of communication is equally seen in the way regulators, patients and the medical community gain access to information, data and obtain feedback. Clinuvel is well aware of this and consistency in our operations helps to communicate its objectives.

(more…)

Bookmark and Share

The fear of what lay ahead

Wednesday, February 10th, 2010

“The fear of what lay ahead” is our latest webcast exploring the impact of EPP upon individuals, their families and loved ones.

Wendy and Ralph are the proud parents of two daughters, who were both diagnosed with Erythropoietic Protoporphyria (EPP), although their first daughter suffered for almost three years before the correct diagnosis of EPP was arrived at.

In this short film they discuss the fear, confusion and distress they endured as a result of grappling with EPP’s severity, invisibility and often unknown and misunderstood nature, all the while unable to treat or protect their children.

Clinuvel would like to extend its thanks and appreciation to Ralph, Wendy, Angela and Lyndal for allowing us to share their story.

Bookmark and Share